BIOSENSE WEBSTER INC THMCL SMTCH SF BID, TC, D-F; CARDIAC ABLATION PERCUTANEOUS CATHETER
|
Back to Search Results |
|
Model Number D134805 |
Device Problem
Patient Device Interaction Problem (4001)
|
Patient Problem
Stroke/CVA (1770)
|
Event Date 04/01/2018 |
Event Type
Injury
|
Manufacturer Narrative
|
Since no device has been received for analysis, no product investigation can be performed, and the customer complaint cannot be confirmed.Manufacturer record evaluation cannot be conducted because the no lot number was provided by the customer.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc.Or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Event Description
|
It was reported that a patient underwent an atrial fibrillation (afib) ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter.The patient suffered a cerebrovascular accident.¿thermocol smart touch sf "(model number: d134805) was used.After the procedure, cerebral infarction developed, and is currently investigating the cause.In addition, as a surgery management during catheter ablation treatment, the guideline recommended for act (activated coagulation time) was 300 to 350 seconds, and according to medical records during the treatment, the act was about 210-230 seconds.In this regard, the hospital claims that the act value was intentionally controlled by 200-250 seconds because of the use of ¿ illegation¿ catheters.The procedure was performed in (b)(6) 2018.And the adverse event occurred after the procedure.The event date was not shared.The adverse event was discovered post use of biosense webster products.The physician's opinion, medical intervention, outcome of the adverse event , information about extended hospitalization, patient information, generator information, was not shared.Since the event is life threatening and it might result in permanent impairment of a body function or permanent damage to a body structure; or it could require medical or surgical intervention to prevent permanent impairment of a body function or permanent damage to a body structure, it is to be considered serious.
|
|
Search Alerts/Recalls
|
|
|